The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Seizure control and treatment changes in pregnancy: Observations from the EURAP epilepsy pregnancy registry
Abstract
Summary: Purpose: To analyze seizure control, dose adjustments, and other changes of antiepileptic drug (AED) treatment during pregnancy in a large cohort of women with epilepsy entering pregnancy on monotherapy with carbamazepine, lamotrigine, phenobarbital, or valproate. Methods: Seizure control and AED treatment were recorded prospectively in 3,806 pregnancies of 3,451 women with epilepsy taking part in European and International Registry of Antiepileptic Drugs and Pregnancy (EURAP), an international AED and pregnancy registry. Key Findings: Of all cases, 66.6% remained seizure‐free throughout pregnancy. Generalized tonic–clonic seizures (GTCS) occurred in 15.2% of the pregnancies. Women with idiopathic generalized epilepsies were more likely to remain seizure‐free (73.6%) than women with localization‐related epilepsy (59.5%; p < 0.0001). Worsening in seizure control from the first to second or third trimesters occurred in 15.8% of pregnancies. The AED dose was increased during pregnancy in 26.0% and a second AED added to the initial monotherapy in 2.6% of all pregnancies. Seizures were more likely to occur in the first trimester in pregnancies with an increased drug load (35%; increased dose and/or addition of another AED) than in pregnancies without an increased drug load (15.3%) (p < 0.0001). Compared with other monotherapies, pregnancies exposed to lamotrigine were less likely to be seizure‐free, 58.2% (p < 0.0001); had more GTCS, 21.1% (p < 0.0001); had a greater likelihood of deterioration in seizure control from first to second or third trimesters, 19.9% (p < 0.01), and were more likely to require an increase in drug load, 47.7% (p < 0.0001). The mean dose increases from the first to third trimesters were 26% for lamotrigine, 5% for carbamazepine, 11% for phenobarbital, and 6% for valproate. There were 21 cases of status epilepticus (10 convulsive): none with maternal mortality and only one with a subsequent stillbirth. Significance: Although the majority of women remain seizure‐free throughout pregnancy, our data suggest that a more proactive approach to adjusting the dose of all AED s in pregnancy should be considered, in particular for those pregnancies with seizures occurring in the first trimester and those exposed to lamotrigine, to reduce the risk of deterioration in seizure control.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Saving Mothers’ Lives: Reviewing maternal deaths to make motherhood safer: 2006–2008
(2011) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2010.02847.x · Cited by 2,994
Morrow, J. (2006) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.074203 · Cited by 880
Tomson, T., Battino, D., Bonizzoni, E., Craig, J., Lindhout, D., Sabers, A., Perucca, E., & Vajda, F. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70107-7 · Cited by 751
Self-citationComparative safety of antiepileptic drugs during pregnancy
Hernández-Díaz, S., Smith, C. R., Shen, A., Mittendorf, R., Hauser, W. A., Yerby, M., Holmes, L. B., For the North American AED Pregnancy Registry, North American AED (Antiepileptic Drug) Pregnancy Registry, Cragan, J., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e3182574f39 · Cited by 620
The longer term outcome of children born to mothers with epilepsy
Adab, N. (2004) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.029132 · Cited by 580
(2009) · Neurology · doi:10.1212/wnl.0b013e3181a6b312 · Cited by 428
Seizure control and treatment in pregnancy: Observations from the EURAP Epilepsy Pregnancy Registry
The EURAP Study Group (2006) · Neurology · doi:10.1212/01.wnl.0000195888.51845.80 · Cited by 331
Lamotrigine in pregnancy: Clearance, therapeutic drug monitoring, and seizure frequency
Pennell, P. B., Peng, L., Newport, D. J., Ritchie, J. C., Koganti, A., Holley, D. K., Newman, M., & Stowe, Z. N. (2008) · Neurology · doi:10.1212/01.wnl.0000289511.20864.2a · Cited by 291
Teratogenic effects of antiepileptic drugs
Tomson, T., & Battino, D. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70103-5 · Cited by 271
Self-citationTomson, T., Landmark, C. J., & Battino, D. (2013) · Epilepsia · doi:10.1111/epi.12109 · Cited by 269
Self-citation
Cited by
Drug treatment of epilepsy in adults
Schmidt, D., & Schachter, S. C. (2014) · BMJ · doi:10.1136/bmj.g254 · Cited by 323
Tomson, T., Battino, D., & Perucca, E. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00314-2 · Cited by 266
Self-citationTomson, T., Battino, D., Bromley, R., Kochen, S., Meador, K., Pennell, P., & Thomas, S. V. (2019) · Epileptic Disorders · doi:10.1684/epd.2019.1105 · Cited by 256
Self-citation(2019) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000003072 · Cited by 147
Metadata
- Authors
- Battino, D., Tomson, T., Bonizzoni, E., Craig, J., Lindhout, D., Sabers, A., Perucca, E., Vajda, F., & EURAP Study Group
- Venue
- Epilepsia
- Publisher
- Wiley
- Published
- 2013-07-12
- Volume
- 54
- Issue
- 9
- Pages
- 1621-1627
- ISSN
- 0013-9580 (ISSN-L)
- 1528-1167
- OpenAlex
- W2172263007
- Cited by
- 298
- References
- 16
- FWCI
- 18.73
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Seizure control and treatment changes in pregnancy: Observations from the EURAP epilepsy pregnancy registry. https://app.cochat.ai/papers/10.1111/epi.12302
- The paper
- Battino, D., Tomson, T., Bonizzoni, E., Craig, J., Lindhout, D., Sabers, A., Perucca, E., Vajda, F., & EURAP Study Group. (2013). Seizure control and treatment changes in pregnancy: Observations from the EURAP epilepsy pregnancy registry. Epilepsia. https://doi.org/10.1111/epi.12302
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.